Xcout IntelLeonaBio, Inc.
LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of neurodegenerative conditions. The company's active development portfolio encompasses ATH-1105, an experimental therapy for amyotrophic lateral sclerosis (ALS) that is currently undergoing Phase 1 clinical assessment. Similarly, ATH-1020 is also in Phase 1 trials, targeting various neurodegenerative disorders. Furthermore, LeonaBio has an array of earlier-stage compounds in preclinical research. The company, which was originally established as Athira Pharma, Inc., rebranded itself as LeonaBio, Inc. in January 2026. Founded in 2011, its corporate headquarters are situated in Bothell, Washington.
Subscribe to see LeonaBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LeonaBio, Inc. at a glance
LeonaBio, Inc. is a biotech company headquartered in Bothell, United States. It is publicly listed (LONA) with a market capitalisation of $54.9M. Xcout tracks 23 named people at LeonaBio, Inc., including Mark J. Litton (President, Chief Executive Officer & Director).
LeonaBio, Inc. leadership
- Mark J. LittonPresident, Chief Executive Officer & Director
- Mark LittonPresident & Chief Executive Officer
- Robert RenningerChief Financial Officer
- Kevin ChurchChief Scientific Officer
- Javier San MartinChief Medical Officer
- Mark F. WorthingtonGeneral Counsel, Chief Compliance Officer & Corporate Secretary
17 more named people on record for LeonaBio, Inc., with roles, board committees and tenure — see the full roster →
Get LeonaBio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on LeonaBio, Inc. in Xcout Intel
- 23 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access